抗菌剂
铜绿假单胞菌
插入(复合材料)
生物膜
硅酮
导管
透析
一氧化氮
材料科学
金黄色葡萄球菌
生物医学工程
微生物学
细菌
医学
外科
生物
复合材料
内分泌学
遗传学
作者
Joshua C. Doverspike,Shale J. Mack,Amy Luo,Blake Stringer,Shelby Reno,Marie S. Cornell,Álvaro Rojas-Peña,Jianfeng Wu,Chuanwu Xi,Alexander S. Yevzlin,Mark E. Meyerhoff
标识
DOI:10.1021/acsami.0c13230
摘要
The use of tunneled dialysis catheters (TDCs) for patients in need of hemodialysis treatments (HDs) causes a significant number of bloodstream infections (BSIs), with very few viable preventative/treatment methods. Use of antibiotics is relatively ineffective due to the development of multidrug-resistant bacterial strains and the inability to penetrate bacterial biofilms. Nitric oxide (NO) is an endogenous gas molecule that has broad-spectrum antimicrobial/antibiofilm activity. In this study, the potential of creating a NO-releasing insert device that is attached onto the hub region cap of TDCs and locally releases NO within the TDC hub is evaluated for its antimicrobial/antibiofilm effectiveness. The NO-releasing insert contains the natural NO donor S-nitrosoglutathione (GSNO), along with zinc oxide (ZnO) nanoparticles to accelerate NO release from the GSNO, within a short silicone tube that is sealed at both ends and attached to the catheter cap. An in vitro 3-d-long antimicrobial study using catheter hubs yielded >6.6 log reductions of both Pseudomonas aeruginosa and Staphylococcus aureus for the NO-releasing insert device compared to controls. Two 14-d-long sheep studies demonstrated that the NO-releasing insert devices are exceptionally potent at preventing bacteria/biofilm growth on the inner lumen walls of TDCs compared to controls that have no preventative treatment devices as well as implanted TDCs that have commercially available chlorhexidine-treated insert devices placed within the hub regions.
科研通智能强力驱动
Strongly Powered by AbleSci AI